Emilio J. Rey
Cadiz, AN, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Cost-effectiveness of second- or third-line treatment with tisotumab vedotin for metastatic or recurrent cervical cancer.
Journal: Expert review of pharmacoeconomics & outcomes research
Published: December 12, 2025
Economic Evaluation of Treatment With Trastuzumab Deruxtecan for HER2-Low Advanced or Metastatic Breast Cancer in Previously Treated Patients.
Journal: PharmacoEconomics - open
Published: June 15, 2025
Correspondence on "Immune checkpoint inhibitor combinations for patients with advanced endometrial cancer: a network meta-analysis and cost-utility analysis" by Zhu and colleagues.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: January 20, 2025
[Translated article] Influence of age on the efficacy of immunochemotherapy in non-small cell lung cancer.
Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria
Published: December 09, 2024
Guideline for the economic evaluation of medicines: a proposal by the Spanish National Health System's Advisory Committee for Pharmaceutical Financing.
Journal: Gaceta sanitaria
Published: July 15, 2024
Economic assessment of abemaciclib for the adjuvant treatment of luminal HER2- breast cancer from the perspective of the Spanish health system.
Journal: The European journal of health economics : HEPAC : health economics in prevention and care
Published: August 18, 2023
Safety considerations during prescription of non-steroidal anti-inflammatory drugs (NSAIDs), through a review of systematic reviews.
Journal: Anales del sistema sanitario de Navarra
Published: June 25, 2021
Cost-utility of talazoparib monotherapy treatment for locally advanced or metastatic breast cancer in Spain.
Journal: Breast (Edinburgh, Scotland)
Published: December 02, 2020
Cost-effectiveness of Evolocumab. Response.
Journal: Revista espanola de cardiologia (English ed.)
Published: May 14, 2018
Cost-effectiveness and Budget Impact of Treatment with Evolocumab Versus Statins and Ezetimibe for Hypercholesterolemia in Spain.
Journal: Revista espanola de cardiologia (English ed.)
Published: November 03, 2017
Last Updated: 09/26/2026